Lv3
380 积分 2023-09-12 加入
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
3个月前
已完结
Gene–environment interactions shape the host–microbial interface in inflammatory bowel disease
3个月前
已完结
The global burden of inflammatory bowel disease: from 2025 to 2045
3个月前
已完结
The global burden of inflammatory bowel disease: from 2025 to 2045
3个月前
已完结
Revolutionizing IBD therapy: Insights into contemporary treatment strategies
5个月前
已完结
Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore
8个月前
已完结
Discovery of Phenylacylpiperidine as Novel sEH Inhibitors through Scaffold Hopping of Natural Stilbene
8个月前
已完结
Synthesis and Properties of N,N′-Disubstituted Ureas and Their Isosteric Analogs Containing Polycyclic Fragments: XI. 1-[(Adamantan-1 yl)alkyl]-3-arylselenoureas
9个月前
已完结
RIPK2 inhibitors for disease therapy: Current status and perspectives
9个月前
已完结
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
9个月前
已完结
皖公网安备34019202002308
